Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Feld

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Immunotherapy|May 21, 2016
Targeting PD-L1 for non-small-cell lung cancerEmily Feld, Leora Horn
Oncotargets and Therapy|August 4, 2017
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectivesEmily Feld, Leora Horn
Immunotherapy|August 29, 2018
Immunotherapy in melanomaEmily Feld, Tara C Mitchell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2016
Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung CancerEmily Castellanos, Emily Feld, Leora Horn
Clinical Lung Cancer|March 14, 2019
Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and PracticesEmily Feld, Eric K Singhi, Sharon Phillips, et al.
JCO Precision Oncology|September 11, 2020
Clinical Response to Anti-Programmed Death 1 After Response and Subsequent Progression on Anti-Programmed Death Ligand 1 TherapyEmily H Castellanos, Emily Feld, Monica V Estrada, et al.
JMIR Cancer|July 13, 2021
A Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability StudyShun Yu, Anh Le, Emily Feld, et al.
JAMA Dermatology|July 30, 2025
Use of Dupilumab to Manage Antibody-Drug Conjugate-Induced Cutaneous ToxicitiesIan Nykaza, Stephen W Dusza, Jonathan E Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 16, 2016
Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF InhibitionDouglas B Johnson, Eirini Pectasides, Emily Feld, et al.
European Urology|August 1, 2019
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial CancerEmily Feld, Joanna Harton, Neal J Meropol, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Immunotherapy|May 21, 2016
Targeting PD-L1 for non-small-cell lung cancerEmily Feld, Leora Horn
Oncotargets and Therapy|August 4, 2017
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectivesEmily Feld, Leora Horn
Immunotherapy|August 29, 2018
Immunotherapy in melanomaEmily Feld, Tara C Mitchell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2016
Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung CancerEmily Castellanos, Emily Feld, Leora Horn
Clinical Lung Cancer|March 14, 2019
Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and PracticesEmily Feld, Eric K Singhi, Sharon Phillips, et al.
JCO Precision Oncology|September 11, 2020
Clinical Response to Anti-Programmed Death 1 After Response and Subsequent Progression on Anti-Programmed Death Ligand 1 TherapyEmily H Castellanos, Emily Feld, Monica V Estrada, et al.
JMIR Cancer|July 13, 2021
A Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability StudyShun Yu, Anh Le, Emily Feld, et al.
JAMA Dermatology|July 30, 2025
Use of Dupilumab to Manage Antibody-Drug Conjugate-Induced Cutaneous ToxicitiesIan Nykaza, Stephen W Dusza, Jonathan E Rosenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 16, 2016
Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF InhibitionDouglas B Johnson, Eirini Pectasides, Emily Feld, et al.
European Urology|August 1, 2019
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial CancerEmily Feld, Joanna Harton, Neal J Meropol, et al.
Pageof 2